Daiwa Securities Group Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,307
Total Value
15007955
Accession Number
0001481045-25-000006
Form Type
13F-HR
Manager Name
Daiwa Securities Group Inc.
Data Enrichment
93% identified
1,218 identified89 unidentified

Holdings

1,307 positions
Manager:
Search and click to pin securities to the top
Page 62 of 64
Arbutus Biopharma Corp
Shares:
395(+0.0%)
Value:
$1.0K(+0.0%)
PHIBRO ANIMAL HEALTH CORP
Shares:
38(+0.0%)
Value:
$1.0K(+0.0%)
922042858
Shares:
30(+0.0%)
Value:
$1.0K(+0.0%)
Taysha Gene Therapies, Inc.
Shares:
691(+0.0%)
Value:
$1.0K(+0.0%)
MARAVAI LIFESCIENCES HOLDINGS, INC.
Shares:
490(+0.0%)
Value:
$1.0K(-66.7%)
Prime Medicine, Inc.
Shares:
398(+0.0%)
Value:
$1.0K(+0.0%)
EyePoint Pharmaceuticals, Inc.
Shares:
144(+0.0%)
Value:
$1.0K(+0.0%)
Erasca, Inc.
Shares:
1074(+0.0%)
Value:
$1.0K(-66.7%)
Mind Medicine (MindMed) Inc.
Shares:
242(+0.0%)
Value:
$1.0K(-50.0%)
Atea Pharmaceuticals, Inc.
Shares:
242(+0.0%)
Value:
$1.0K(+0.0%)
Aquestive Therapeutics, Inc.
Shares:
500
Value:
$1.0K
REGENXBIO Inc.
Shares:
146(+0.0%)
Value:
$1.0K(+0.0%)
Solid Biosciences Inc.
Shares:
400
Value:
$1.0K
921946885
Shares:
18
Value:
$1.0K
Voyager Therapeutics, Inc.
Shares:
201(+0.0%)
Value:
$1.0K(+0.0%)
Cartesian Therapeutics, Inc.
Shares:
84(+0.0%)
Value:
$1.0K(-50.0%)
PRECIGEN, INC.
Shares:
708(+0.0%)
Value:
$1.0K(+0.0%)
Altimmune, Inc.
Shares:
235(+0.0%)
Value:
$1.0K(-50.0%)
Annexon, Inc.
Shares:
352(+0.0%)
Value:
$1.0K(-50.0%)
Amylyx Pharmaceuticals, Inc.
Shares:
266(+0.0%)
Value:
$1.0K(+0.0%)